Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 39
- Press Release
- Press Release PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for the Treatment of mTNBC
- PharmAbcine
- 28 Dec 2021
- Views2131
- 0
- 38
- Press Release
- Press Release PharmAbcine’s next-generation bispecific antibody drug discovery project wins a New Drug Development Fund from the government
- PharmAbcine
- 13 Dec 2021
- Views1835
- 0
- 37
- Press Release
- Press Release PharmAbcine to participate in J.P. Morgan Healthcare Conference and Biotech Showcase during “J.P. Morgan Week 2022”
- PharmAbcine
- 7 Dec 2021
- Views1970
- 0
- 36
- Press Release
- Press Release PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
- PharmAbcine
- 20 Oct 2021
- Views1542
- 0
- 35
- Press Release
- Press Release PharmAbcine to Participate in BIO-Europe 2021
- PharmAbcine
- 21 Sep 2021
- Views1578
- 0
- 34
- Press Release
- Press Release PharmAbcine to Participate in ACCESS CHINA Biotech Forum
- PharmAbcine
- 14 Sep 2021
- Views1440
- 0
- 33
- Press Release
- Press Release PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer
- PharmAbcine
- 10 Sep 2021
- Views1873
- 0
- 32
- Press Release
- Press Release PharmAbcine receives the ‘Best Poster Award’ for its additional nonclinical data presentation of PMC-309 at KSMO 2021
- PharmAbcine
- 6 Sep 2021
- Views3261
- 0
- 31
- Press Release
- Press Release PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC
- PharmAbcine
- 6 Sep 2021
- Views1750
- 0
- 30
- Press Release
- Press Release PharmAbcine to Participate in H.C. Wainright 23rd Annual Global Investment Conference
- PharmAbcine
- 23 Aug 2021
- Views1449
- 0